GENE ONLINE|News &
Opinion
Blog

2025-04-28|

Four-Week Interval Identified as Optimal for Circulating Tumor DNA Testing

by Mark Chiang
Share To

NEWSFLASH

Researchers determined that a four-week timeframe is optimal for circulating tumor DNA (ctDNA) testing. The study identified this specific time point as most effective for detecting ctDNA. The investigation centered around pinpointing the ideal window for ctDNA detection. Findings indicated that waiting four weeks before testing yielded the most reliable results. The research focused specifically on the temporal aspect of ctDNA testing, highlighting the importance of the interval between initial assessment and subsequent analysis.

Newsflash | Powered by GeneOnline AI
Date: April 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
LATEST
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top